Breast milk-derived Lactiplantibacillus plantarum FN029 mitigates food allergy in mice via intestinal barrier enhancement and Th1/Th2 modulation

XIE Qiuyan, SUN Jin, QI Ce, JIANG Shanyu, YE Danni, YU Renqiang

Chinese Journal of Child Health Care ›› 2026, Vol. 34 ›› Issue (4) : 375-382.

PDF(4712 KB)
PDF(4712 KB)
Chinese Journal of Child Health Care ›› 2026, Vol. 34 ›› Issue (4) : 375-382. DOI: 10.11852/zgetbjzz2025-1062
Special Column on Nutrition/Feeding and Allergic Diseases

Breast milk-derived Lactiplantibacillus plantarum FN029 mitigates food allergy in mice via intestinal barrier enhancement and Th1/Th2 modulation

  • XIE Qiuyan1, SUN Jin2, QI Ce2, JIANG Shanyu1, YE Danni1, YU Renqiang1
Author information +
History +

Abstract

Objective To investigate the ameliorative effects and potential mechanisms of breast milk-derived Lactiplantibacillus plantarum FN029 on β-lactoglobulin (β-LG)-induced food allergy in mice, in order to provide reference for the prevention and treatment of food allergy. Methods BALB/c mice were randomly divided into a control group, a food allergy group (induced by β-LG), and an FN029 intervention group.FN029 was administered by oral gavage for intervention.Allergic symptom scores were evaluated.Histopathological staining was performed to assess lung and jejunal injury as well as mast cell infiltration.Serum immunoglobulin and cytokine levels were measured.In addition, mRNA expression of Th1/Th2 cytokines in the jejunum, expression of tight junction proteins, and protein levels of the AKT/mTOR and NF-κB signaling pathways were analyzed. Results Compared with the control group, mice in the food allergy group exhibited pronounced allergic symptoms, weight loss, and increased spleen index.Lung and jejunal tissues were damaged, with increased mast cell infiltration.Serum levels of total IgE, β-LG-specific IgE, IgG1, histamine, and IL-4 were significantly elevated, accompanied by upregulated jejunal Th2 cytokine IL-4 and Th1 cytokine IFN-γ levels.Furthermore, expression of intestinal tight junction proteins (ZO-1, Occludin, Claudin-1) was decreased, and phosphorylation levels of key proteins in the AKT/mTOR and NF-κB signaling pathways were abnormally increased (P<0.05).FN029 intervention significantly ameliorated allergic symptoms and signs, alleviated tissue damage and mast cell aggregation, downregulated serum IgE, histamine, and jejunal IL-4 levels, and upregulated IFN-γ, effectively correcting the Th1/Th2 imbalance.In addition, FN029 promoted the restoration of intestinal tight junction proteins and significantly inhibited phosphorylation activation of AKT and NF-κB (P<0.05). Conclusions Lactiplantibacillus plantarum FN029 effectively alleviates food allergy symptoms in mice, and its underlying mechanisms may be related to inhibition of allergen-induced activation of the AKT/mTOR and NF-κB inflammatory signaling pathways, restoration of the intestinal physical barrier, and modulation of Th1/Th2 immune balance.

Key words

food allergy / Lactiplantibacillus plantarum / β-lactoglobulin / intestinal barrier / AKT/mTOR signaling pathway

Cite this article

Download Citations
XIE Qiuyan, SUN Jin, QI Ce, JIANG Shanyu, YE Danni, YU Renqiang. Breast milk-derived Lactiplantibacillus plantarum FN029 mitigates food allergy in mice via intestinal barrier enhancement and Th1/Th2 modulation[J]. Chinese Journal of Child Health Care. 2026, 34(4): 375-382 https://doi.org/10.11852/zgetbjzz2025-1062

References

[1] Rizzi A, Gangemi S.Food allergy: Epidemiology,pathogenesis, diagnosis, and treatment [J].J Clin Med, 2024, 13(19): 291-307.
[2] Bartha I, Almulhem N, Santos AF.Feast for thought: A comprehensive review of food allergy 2021-2023 [J].J Allergy Clin Immunol, 2024, 153(3): 576-594.
[3] Bian S, Wang R, Xu T, et al.Characteristics of cow′s milk allergy and sensitization in Chinese patients [J].Chin Med J (Engl), 2022, 135(22): 2738-2740.
[4] Ogulur I, Mitamura Y, Yazici D, et al.Type 2 immunity in allergic diseases [J].Cell Mol Immunol, 2025, 22(3): 211-242.
[5] Oettgen HC.Mast cells in food allergy: Inducing immediate reactions and shaping long-term immunity [J].J Allergy Clin Immunol, 2023, 151(1): 21-25.
[6] Haque M, Kaminsky L, Abdulqadir R, et al.Lactobacillus acidophilus inhibits the TNF-alpha-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-kappaB activation [J].Front Immunol, 2024, 15: 1348010.
[7] Jiang L, Zhang L, Xia J, et al.Probiotics supplementation during pregnancy or infancy on multiple food allergies and gut microbiota: A systematic review and meta-analysis [J].Nutr Rev, 2025, 83(2): e25-e41.
[8] Hu P, Sun J, Gao R, et al.Harnessing the power of breast milk: How Lactiplantibacillus plantarum FN029 from rural western China mitigates severe atopic dermatitis in mice through retinol metabolism activation [J].Food Funct, 2025, 16(6): 2230-2246.
[9] Gong H, Li T, Liang D, et al.Milk fat globule membrane supplementation protects against β-lactoglobulininduced food allergy in mice via upregulation of regulatory T cells and enhancement of intestinal barrier in a microbiota-derived short-chain fatty acids manner [J].Food Sci Hum Wellness, 2024, 13(1): 124-136.
[10] Jiang S, Hou Y, Meng L, et al.Effect of Lactiplantibacillus plantarum HM-22 on immunoregulation and intestinal microbiota in alpha-lactalbumin-induced allergic mice [J].Food Funct, 2021, 12(19): 8887-8898.
[11] Paparo L, Nocerino R, Ciaglia E, et al.Butyrate as a bioactive human milk protective component against food allergy [J].Allergy, 2020, 76(5): 1398-1415.
[12] Fu W, Zheng Z, Zhao J, et al.Allergic disease and sensitization disparity in urban and rural China: A EuroPrevall-INCO study [J].Pediatr Allergy Immunol, 2022, 33(12): e13903.
[13] Berni Canani R, Paparo L, Nocerino R, et al.Gut microbiome as target for innovative strategies against food allergy [J].Front Immunol, 2019, 10: 191.
[14] 程爽,王菊.益生菌、益生元、合生元和后生元预防与治疗牛奶蛋白过敏的研究进展 [J].中国儿童保健杂志, 2024, 32(9): 989-993.
Cheng S, Wang J.Research progress on the prevention and treatment of cow′s milk protein allergy with probiotics, prebiotics, synbiotics and postbiotics[J].Chin J Child Health Care, 2024, 32(9): 989-993.(in Chinese)
[15] Duan C, Ma L, Qin M, et al.Potential of Lactobacillus plantarum A56 in relieving food allergy through immunoregulation, antioxidation, and reshaping intestinal microbiota [J].J Nutr Biochem, 2024, 125: 109560.
[16] Pei Z, Qian L, Miao T, et al.Uncovering the mechanisms underlying the efficacy of probiotic strains in mitigating food allergies: An emphasis on gut microbiota and indoleacrylic acid [J].Front Nutr, 2024, 12(11): 1523842.
[17] Meng L, Xie H, Li Z, et al.Gut-mammary pathway: Breast milk microbiota as a mediator of maternal gut microbiota transfer to the infant gut [J].J Funct Foods, 2025, 124: 106620.
[18] Turqueti-Neves A, Otte M, Schwartz C, et al.The extracellular domains of IgG1 and T cell-derived IL-4/IL-13 are critical for the polyclonal memory IgE response in vivo [J].PLoS Biol, 2015, 13(11): e1002290.
[19] Duan C, Ma L, Yu J, et al.Oral administration of Lactobacillus plantarum JC7 alleviates OVA-induced murine food allergy through immunoregulation and restoring disordered intestinal microbiota [J].Eur J Nutr, 2023, 62(2): 685-698.
[20] Shi J, Dong P, Liu C, et al.Lactobacillus rhamnosus Probio-M9 alleviates OVA-sensitized food allergy through modulating gut microbiota and its metabolism [J].Food Funct, 2023, 14(24): 10784-10795.
[21] Poto R, Fusco W, Rinninella E, et al.The role of gut microbiota and leaky gut in the pathogenesis of food allergy [J].Nutrients, 2023, 16(1): 92.
[22] Gou HZ, Zhang YL, Ren LF, et al.How do intestinal probiotics restore the intestinal barrier? [J].Front Microbiol, 2022, 14(13): 929346.
[23] Cao LH, He HJ, Zhao YY, et al.Food allergy-induced autism-like behavior is associated with gut microbiota and brain mTOR signaling [J].J Asthma Allergy, 2022, 15: 645-664.
[24] Mohseni AH, Casolaro V, Bermudez-Humaran LG, et al.Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response [J].Gut Microbes, 2021, 13(1): 1-17.
[25] Guo Q, Jin Y, Chen X, et al.NF-κB in biology and targeted therapy: New insights and translational implications [J].Signal Transduct Target Ther, 2024, 9(1): 53.
[26] Prescott JA, Mitchell JP, Cook SJ.Inhibitory feedback control of NF-κB signalling in health and disease [J].Biochem J, 2021, 478(13): 2619-2664.
PDF(4712 KB)

Accesses

Citation

Detail

Sections
Recommended

/